Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study.
Pugh, S Bowers, M Ball, A Falk, S Finch-Jones, M Valle, Juan W O'Reilly, D Siriwardena, A Hornbuckle, J Rees, M
Pugh, S
Bowers, M
Ball, A
Falk, S
Finch-Jones, M
Valle, Juan W
O'Reilly, D
Siriwardena, A
Hornbuckle, J
Rees, M
Citations
Altmetric:
Abstract
The addition of cetuximab (CTX) to perioperative chemotherapy (CT) for operable colorectal liver metastases resulted in a shorter progression-free survival. Details of disease progression are described to further inform the primary study outcome.
Description
Date
2016-08-09
Publisher
Collections
Keywords
Type
Article
Citation
Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study. 2016, 115 (4):420-4 Br. J. Cancer